"Ergocalciferols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.
| Descriptor ID |
D004872
|
| MeSH Number(s) |
D04.210.500.247.222.474 D04.210.500.247.808.412 D04.210.500.812.768.462 D10.570.938.439
|
| Concept/Terms |
Vitamin D 2- Vitamin D 2
- Vitamin D2
- D2, Vitamin
- Ergocalciferol
|
Below are MeSH descriptors whose meaning is more general than "Ergocalciferols".
Below are MeSH descriptors whose meaning is more specific than "Ergocalciferols".
This graph shows the total number of publications written about "Ergocalciferols" by people in this website by year, and whether "Ergocalciferols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 4 | 8 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 3 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ergocalciferols" by people in Profiles.
-
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021 Jul 26; 13(8).
-
Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 Patients. Nutrients. 2021 Jun 22; 13(7).
-
Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing. Cell Metab. 2020 11 03; 32(5):704-709.
-
Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series. Am J Ther. 2020 Sep/Oct; 27(5):e485-e490.
-
Arterial stiffness: A clinical index or a research tool? Hellenic J Cardiol. 2019 Mar - Apr; 60(2):69-71.
-
Vitamin D: A cardiovascular risk biomarker or a treatment target? Hellenic J Cardiol. 2019 Mar - Apr; 60(2):114-116.
-
Questioning the Safety of Calcidiol in Hemodialysis Patients. Nutrients. 2019 04 26; 11(5).
-
Paricalcitol attenuates TGF-ß1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome. FASEB J. 2019 02; 33(2):3035-3050.
-
Treatments for secondary hyperparathyroidism in hemodialysis. Pol Arch Intern Med. 2017 12 22; 127(12):807-809.
-
Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017 11 03; 11:CD011564.